Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now later-stage tilt small index

Tonsillitis: later-stage trial registry

5 of 7 indexed Tonsillitis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Tonsillitis: 7 US clinical trials tracked, 5 recruiting.

Tonsillitis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Healthcare of Atlanta, running 1 of these trials.

Enrollment posture brief

Registry condition tonsillitis

OPEN 5 | RECR 71% | LATE 3 | EARLY 0 | RANK #2497 | SPON 1

Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)

ACL Tear71.4%Tonsillitis (this)71%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Tonsillitis

Tonsillitis lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tonsillitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tonsillitis is recruiting above its size-band peers.

    5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Tonsillitis trials is spread across many organizations.

    Children's Healthcare of Atlanta accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Tonsillitis enrolment sits around 95 participants.

    Median target enrolment is 95 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Tonsillitis research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31Phase 42

Phase Distribution

PhaseTrial count
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Tonsillitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Combined Acetaminophen and Ibuprofen Drug
1 trials
Alternating Acetaminophen and Ibuprofen Drug
1 trials
Auricular acupuncture Other
1 trials
Fentanyl/Hydromorphone Drug
1 trials
Tonsillectomy Procedure
1 trials
Lateral pharyngoplasty Procedure
1 trials
Morphine Drug
1 trials
Gabapentin Drug
1 trials

US sites by state

Facility locations filed on Tonsillitis trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Missouri 1 trials
Maryland 1 trials
Massachusetts 1 trials
Indiana 1 trials
Georgia 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tonsillitis page

7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tonsillitis condition card totals 7 registered trials; most-linked intervention Combined Acetaminophen and Ibuprofen; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.